C-reactive protein level predicts prognosis in patients with locoregionally advanced laryngeal carcinoma treated with chemoradiotherapy

Tumor Biology

Volumn 33, Issue 3, 2012, Pages 891-895

  Zeng, Yue Can ^a   Xue, Ming ^a   Chi, Feng ^a   Xu, Zhao Guo ^a   Fan, Guo Liang ^b   Wu, Rong ^a   Fan, Yu Chen ^c   Zhong, Wen Zhao ^d   Wang, Si Liang ^a   Zhang, Xiao Ye ^a   Wu, Li Na ^a   Chen, Xiao Dong ^a   Jin, Xue Ying ^a   Duan, Qiong Yu ^a   Xu, Ru ^a   Chen, Wei ^a   Qian, Hao Chu ^a   Xiao, Yu Ping ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b Harbin First Hospital   (China)

^c SHANDONG UNIVERSITY   (China)

^d GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

C reactive protein; Cancer specific survival; Chemoradiotherapy; Laryngeal carcinoma

Indexed keywords

C REACTIVE PROTEIN; CARBOPLATIN; CISPLATIN; DOCETAXEL; FLUOROURACIL; PACLITAXEL; PLATINUM;

ADULT; ADVANCED CANCER; AGED; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CHEMORADIOTHERAPY; CONTROLLED STUDY; DISEASE ASSOCIATION; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; LARYNGECTOMY; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; NECK DISSECTION; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; REVIEW; SURVIVAL RATE; TREATMENT RESPONSE; ARTICLE; CANCER STAGING; CARCINOMA; LARYNX TUMOR; METABOLISM; MIDDLE AGED; MORTALITY; PROGNOSIS; SURVIVAL;

AGED; C-REACTIVE PROTEIN; CARCINOMA; CHEMORADIOTHERAPY; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 84863563177     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-012-0330-6     Document Type: Review

References (13)

1. Mantz CA, Vokes EE, Kies MS, Mittal B, Witt ME, List MA, et al. Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer. Ann Oncol. 2001;12(3):343-7.
2. Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349(22):2091-8.
3. McMillan DC, Canna K, McArdle CS. Systemic inflammatory response predicts survival following curative resection of colorectal cancer. Br J Surg. 2003;90(2):215-9.
4. Guillem P, Triboulet JP. Elevated serum levels of C-reactive protein are indicative of a poor prognosis in patients with esophageal cancer. Dis Esophagus. 2005;18(3):146-50.
5. Kulpa J, Stasik Z, Skołyszewski J. Predictive value of SCC-Ag, CYFRA 21-1 and selected acute phase proteins in radiotherapy of pharyngeal and laryngeal cancer. A preliminary report Neoplasma. 2004;51(2):103-9.
6. Yang L, Guo ZM, Zeng ZY. Treatments and outcomes of 10 cases of subglottic cancer and literature review. Ai Zheng. 2007;26(3):325-8.
7. Duffy SA, Taylor JM, Terrell JE, Islam M, Li Y, Fowler KE, et al. Interleukin-6 predicts recurrence and survival among head and neck cancer patients. Cancer. 2008;113(4):750-7.
8. Druzgal CH, Chen Z, Yeh NT, Thomas GR, Ondrey FG, Duffey DC, et al. A pilot study of longitudinal serum cytokine and angiogenesis factor levels as markers of therapeutic response and survival in patients with head and neck squamous cell carcinoma. Head Neck. 2005;27(9):771-84.
9. Conti-Freitas LC, Foss-Freitas MC, Mamede RC, Foss NT. Effect of BCG stimulus on proinflammatory cytokine production in laryngeal cancer. Cancer Immunol Immunother. 2009;58(1):25-9.
10. Ganter U, Arcone R, Toniatti C, Morrone G, Ciliberto G. Dual control of C-reactive protein gene expression by interleukin-1 and interleukin-6. EMBO J. 1989;8(12):3773-9.
11. Heikkilä K, Harris R, Lowe G, Rumley A, Yarnell J, Gallacher J, et al. Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis. Cancer Causes Control. 2009;20(1):15-26.
12. Khandavilli SD, Ceallaigh PO, Lloyd CJ, Whitaker R. Serum Creactive protein as a prognostic indicator in patients with oral squamous cell carcinoma. Oral Oncol. 2009;45(10):912-4.
13. Wang DS, Ren C, Qiu MZ, Luo HY, Wang ZQ, Zhang DS. Comparison of the prognostic value of various preoperative inflammation-based factors in patients with stage III gastric cancer. Tumour Biol. 2011. doi:10.1007/s13277-011-0285-z.